Showing results (281-290 of 351) with videos related to

Sort By:
Pageof 36
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
High levels of B cell activating factor during the peritransplantation period are associated with a reduced incidence of acute graft-versus-host disease following myeloablative allogeneic stem cell transplantationByung-Sik Cho, Chang-Ki Min, Hee-Je Kim, et al.
The Korean Journal of Internal Medicine|February 24, 2020
The clinical, laboratory, and radiologic improvement due to siltuximab treatment in idiopathic multicentric Castleman's diseaseGi-June Min, Young-Woo Jeon, Sung-Soo Park, et al.
Blood Advances|January 17, 2024
Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trialGail J Roboz, Guillermo Sanz, Elizabeth A Griffiths, et al.
The Korean Journal of Internal Medicine|July 10, 2025
Association between body mass index and survival after hematopoietic stem cell transplantationHan-Sang Baek, Jong Hyuk Lee, Joonyub Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 14, 2020
Comparison of Myeloablative (CyTBI, BuCy) versus Reduced-Intensity (FluBu2TBI400) Peripheral Blood Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Pretransplant Low WT1 ExpressionSilvia Park, Gi June Min, Sung Soo Park, et al.
Pageof 36